These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 5504550
41. [Personal experience in the treatment of Parkinson's disease with L-Dopa]. Figuerido JA, De la Herrán J. Rev Clin Esp; 1970 Dec 31; 119(6):555-62. PubMed ID: 5509794 [No Abstract] [Full Text] [Related]
42. L-Dopa therapy of Parkinson's disease. (A review of the preliminary experience at West Virginia University). Gutmann L, Martin JD, Gutrecht JA. W V Med J; 1970 Apr 31; 66(4):109-11. PubMed ID: 5264660 [No Abstract] [Full Text] [Related]
43. [Use of L-DOPA in the therapy of parkinsonism]. D'Andrea F, De Divitiis E, Signorelli CD, Cerillo A, Tedeschi G. Rass Int Clin Ter; 1971 Feb 28; 51(4):193-221. PubMed ID: 4930734 [No Abstract] [Full Text] [Related]
44. An analysis of L-dopa-induced dyskinesias in 152 cases of Parkinson's disease. Mones RJ, Elizan TS, Siegel GJ. Neurology; 1970 Apr 28; 20(4):405-6. PubMed ID: 5535050 [No Abstract] [Full Text] [Related]
45. Stimulation of human-growth-hormone secretion by L-dopa. Boyd AE, Lebovitz HE, Pfeiffer JB. N Engl J Med; 1970 Dec 24; 283(26):1425-9. PubMed ID: 5481776 [No Abstract] [Full Text] [Related]
46. Amino acid and dopa levels in plasma and urine from L-dopa-treated patients with Parkinson's disease. Hare TA, Vanna S, Beasley B, Chambers R, Vogel WH. J Lab Clin Med; 1971 Feb 24; 77(2):319-25. PubMed ID: 5540775 [No Abstract] [Full Text] [Related]
47. [Treatment of parkinsonism with L-dopa]. Court J, Kase JC, Palacios E, Mena I. Rev Med Chil; 1971 Jun 24; 99(6):399-401. PubMed ID: 5561157 [No Abstract] [Full Text] [Related]
48. [Oral L-dopa in the modern therapy of parkinsonian syndromes: general considerations; analysis of the first 50 personal cases]. Guidetti B, Giuffrè R. Sist Nerv; 1970 Jun 24; 22(2):196-202. PubMed ID: 5504557 [No Abstract] [Full Text] [Related]
49. Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa). McDowell F, Lee JE, Swift T, Sweet RD, Ogsbury JS, Kessler JT. Ann Intern Med; 1970 Jan 24; 72(1):29-35. PubMed ID: 5410397 [No Abstract] [Full Text] [Related]
50. [Association of L-dopa and other therapeutic methods in treatment of parkinsonian syndromes]. Mingrino S. Sist Nerv; 1970 Jan 24; 22(2):212-5. PubMed ID: 4926920 [No Abstract] [Full Text] [Related]
51. [Clinical experience with L-DOPA in the treatment of parkinsonism]. Chiba T. No To Shinkei; 1970 Dec 24; 22(12):1399-405. PubMed ID: 5536833 [No Abstract] [Full Text] [Related]
52. [Parkinsonism, vitiligo and L-dopa. Contribution to the study of the embryological and functional correlation between nervous system and skin]. Iparraguirre CE. Rev Neuropsiquiatr; 1971 Dec 24; 34(4):274-81. PubMed ID: 5164553 [No Abstract] [Full Text] [Related]
53. Dietary factors in the management of Parkinson's disease. Kempster PA, Wahlqvist ML. Nutr Rev; 1994 Feb 24; 52(2 Pt 1):51-8. PubMed ID: 8183469 [Abstract] [Full Text] [Related]
55. [Treatment of parkinsonism with L-dopa]. Presthus J. Nord Med; 1970 Nov 12; 84(46):1467-8. PubMed ID: 5479940 [No Abstract] [Full Text] [Related]
56. [Clinical results of the intravenous administration of amantadine in patients with parkinsonism]. Caliri F, Di Rosa AE, Meduri M, Megna G, Musolino R, Scuderi D. Minerva Med; 1971 Oct 31; 62(82):3994-6. PubMed ID: 5125062 [No Abstract] [Full Text] [Related]